Medtech startup providing noninvasive and point of care solutions for respiratory and retinal conditions leveraging explainable AI (deep learning and machine learning)

Momentum is derived from funding recency, velocity, round count and scale. Risk reflects registry status and funding staleness.

Docturnal products are designed to make detection of respiratory ailments easy, affordable and in real time (20 seconds)

Health and social work

Source: Ministry of Corporate Affairs company master (open data). Capital figures are as-of the 2021 registry snapshot, not live.

Extracted from Docturnal Private Limited's own website, fetched Jul 2026. Verification badges reflect format/MX checks, not endorsement.